Menu
GeneBe

rs115850223

Variant summary

Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS1

The NM_017950.4(CCDC40):c.2017G>A(p.Asp673Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000577 in 1,614,080 control chromosomes in the GnomAD database, including 5 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0028 ( 1 hom., cov: 33)
Exomes 𝑓: 0.00035 ( 4 hom. )

Consequence

CCDC40
NM_017950.4 missense

Scores

3
14

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:3

Conservation

PhyloP100: 2.35
Variant links:
Genes affected
CCDC40 (HGNC:26090): (coiled-coil domain 40 molecular ruler complex subunit) This gene encodes a protein that is necessary for motile cilia function. It functions in correct left-right axis formation by regulating the assembly of the inner dynein arm and the dynein regulatory complexes, which control ciliary beat. Mutations in this gene cause ciliary dyskinesia type 15, a disorder due to defects in cilia motility. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2011]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.007947803).
BP6
Variant 17-80084770-G-A is Benign according to our data. Variant chr17-80084770-G-A is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 215897.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=2, Uncertain_significance=1}.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00276 (421/152270) while in subpopulation AFR AF= 0.00961 (399/41534). AF 95% confidence interval is 0.00883. There are 1 homozygotes in gnomad4. There are 180 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
CCDC40NM_017950.4 linkuse as main transcriptc.2017G>A p.Asp673Asn missense_variant 13/20 ENST00000397545.9
CCDC40NM_001243342.2 linkuse as main transcriptc.2017G>A p.Asp673Asn missense_variant 13/18

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
CCDC40ENST00000397545.9 linkuse as main transcriptc.2017G>A p.Asp673Asn missense_variant 13/205 NM_017950.4 P2Q4G0X9-1
CCDC40ENST00000574799.5 linkuse as main transcriptn.1554G>A non_coding_transcript_exon_variant 9/161
CCDC40ENST00000374877.7 linkuse as main transcriptc.2017G>A p.Asp673Asn missense_variant 13/185 A2Q4G0X9-2
CCDC40ENST00000572253.5 linkuse as main transcriptn.644G>A non_coding_transcript_exon_variant 2/62

Frequencies

GnomAD3 genomes
AF:
0.00276
AC:
420
AN:
152152
Hom.:
1
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00961
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000851
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000735
Gnomad OTH
AF:
0.00191
GnomAD3 exomes
AF:
0.000734
AC:
183
AN:
249376
Hom.:
0
AF XY:
0.000554
AC XY:
75
AN XY:
135302
show subpopulations
Gnomad AFR exome
AF:
0.00918
Gnomad AMR exome
AF:
0.000840
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.0000327
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000795
Gnomad OTH exome
AF:
0.000330
GnomAD4 exome
AF:
0.000350
AC:
511
AN:
1461810
Hom.:
4
Cov.:
32
AF XY:
0.000305
AC XY:
222
AN XY:
727208
show subpopulations
Gnomad4 AFR exome
AF:
0.0115
Gnomad4 AMR exome
AF:
0.000827
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000232
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000261
Gnomad4 OTH exome
AF:
0.000811
GnomAD4 genome
AF:
0.00276
AC:
421
AN:
152270
Hom.:
1
Cov.:
33
AF XY:
0.00242
AC XY:
180
AN XY:
74464
show subpopulations
Gnomad4 AFR
AF:
0.00961
Gnomad4 AMR
AF:
0.000850
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000735
Gnomad4 OTH
AF:
0.00189
Alfa
AF:
0.000524
Hom.:
1
Bravo
AF:
0.00326
ESP6500AA
AF:
0.00609
AC:
25
ESP6500EA
AF:
0.000357
AC:
3
ExAC
AF:
0.000892
AC:
108
Asia WGS
AF:
0.000577
AC:
2
AN:
3478
EpiCase
AF:
0.000109
EpiControl
AF:
0.0000593

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:3
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Primary ciliary dyskinesia Benign:2
Likely benign, criteria provided, single submitterclinical testingAmbry GeneticsOct 04, 2021This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Likely benign, criteria provided, single submitterclinical testingInvitaeJan 12, 2024- -
Primary ciliary dyskinesia 15 Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 12, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. -
not provided Benign:1
Likely benign, no assertion criteria providedclinical testingDepartment of Pathology and Laboratory Medicine, Sinai Health System-The CCDC40 p.Asp673Asn variant was not identified in the literature nor was it identified in Cosmic. The variant was identified in dbSNP (ID: rs115850223), ClinVar (classified as likely benign by Invitae and as a VUS by Illumina Clinical Services for ciliary dyskinesia) and in LOVD 3.0 (classified as likely benign). The variant was also identified in control databases in 258 of 280770 chromosomes at a frequency of 0.000919 increasing the likelihood this could be a low frequency benign variant (Genome Aggregation Database Feb 27, 2017). The variant was observed in the following populations: African in 215 of 24180 chromosomes (freq: 0.008892), Latino in 31 of 35360 chromosomes (freq: 0.000877), Other in 2 of 7146 chromosomes (freq: 0.00028), European (non-Finnish) in 9 of 128602 chromosomes (freq: 0.00007) and South Asian in 1 of 30594 chromosomes (freq: 0.000033), while the variant was not observed in the Ashkenazi Jewish, East Asian or European (Finnish) populations. The variant occurs outside of the splicing consensus sequence however in silico or computational prediction software programs, (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer) predict a greater than 10% difference in splicing and the creation of a new 5' splice site. The p.Asp673 residue is not conserved in mammals however computational analyses (PolyPhen-2, SIFT, AlignGVGD, BLOSUM, MutationTaster) do not suggest a high likelihood of impact to the protein; this information is not predictive enough to rule out pathogenicity. In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time although we would lean towards a more benign role for this variant. This variant is classified as likely benign. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.084
BayesDel_addAF
Benign
-0.60
T
BayesDel_noAF
Benign
-0.63
Cadd
Benign
13
Dann
Benign
0.92
Eigen
Benign
-0.78
Eigen_PC
Benign
-0.80
FATHMM_MKL
Uncertain
0.80
D
LIST_S2
Benign
0.70
T;T
MetaRNN
Benign
0.0079
T;T
MetaSVM
Benign
-0.98
T
MutationAssessor
Benign
1.8
L;L
MutationTaster
Benign
0.97
N;N
PrimateAI
Benign
0.34
T
PROVEAN
Uncertain
-3.1
D;D
REVEL
Benign
0.15
Sift
Benign
0.12
T;T
Sift4G
Uncertain
0.022
D;D
Polyphen
0.078
.;B
Vest4
0.29
MVP
0.19
MPC
0.18
ClinPred
0.020
T
GERP RS
0.93
Varity_R
0.078
gMVP
0.31

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs115850223; hg19: chr17-78058569; API